China National Pharmaceutical Group Corporation announced its first-quarter performance, with a net profit attributable to the parent company of approximately 14.2 billion yuan, a year-on-year decrease of 10.7%
I'm PortAI, I can summarize articles.
According to the news from Zhitong Finance APP, China National Pharmaceutical Group announced its performance for the first quarter of 2024. The total operating income is approximately RMB 147.266 billion, a year-on-year increase of 1.2%; the net profit attributable to the owners of the parent company is about RMB 1.42 billion, a year-on-year decrease of 10.7%; and the basic earnings per share is RMB 0.46
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments